The Epidemiology of Eye Diseases in Diabetes

The Epidemiology of Diabetes Mellitus: Second Edition

Volumn , Issue , 2008, Pages 475-497

  Wong, Tien Y ^a   Klein, Ron ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Chronic inflammation and diabetic retinopathy; Diabetes eye disease epidemiology; Diabetes risk factor for glaucoma; Diabetic retinopathy demographic variations; Diabetic retinopathy prevalence at baseline; Early treatment for diabetic retinopathy study (ETDRS); retinal vascular diseases and retinal vein occlusion (RVO)

Indexed keywords

EID: 79956361018     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470779750.ch30     Document Type: Chapter

References (244)

1. Congdon, N., Friedman, D.S. and Lietman, T. (2003) Important causes of visual impairment in the world today. The Journal of the American Medical Association, 290 (15), 2057-60.
2. Kempen, J.H., O'Colmain, B.J., Leske, M.C. et al. (2004) The prevalence of diabetic retinopathy among adults in the United States. Archives of Ophthalmology, 122 (4), 552-63.
3. Wilkinson, C.P., Ferris, F.L. III, Klein, R.E. et al. (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology, 110 (9), 1677-82.
4. Kahn, H.A., Leibowitz, H.M., Ganley, J.P. et al. (1977) The Framingham Eye Study. I. Outline and major prevalence findings. American Journal of Epidemiology, 106 (1), 17-32.
5. Ballard, D.J., Melton, L.J. III, Dwyer, M.S. et al. (1986) Risk factors for diabetic retinopathy: a population-based study in Rochester, Minnesota. Diabetes Care, 9 (4), 334-42.
6. Haffner, S.M., Fong, D., Stern, M.P. et al. (1988) Diabetic retinopathy in Mexican Americans and non-Hispanic whites. Diabetes, 37 (7), 878-84.
7. Hamman, R.F., Mayer, E.J., Moo-Young, G.A. et al. (1989) Prevalence and risk factors of diabetic retinopathy in non-Hispanic whites and Hispanics with NIDDM. San Luis Valley Diabetes Study. Diabetes, 38 (10), 1231-7.
8. Kostraba, J.N., Klein, R., Dorman, J.S. et al. (1991) The epidemiology of diabetes complications study. IV. Correlates of diabetic background and proliferative retinopathy. American Journal of Epidemiology, 133 (4), 381-91.
9. West, S.K., Klein, R., Rodriguez, J. et al. (2001) Diabetes and diabetic retinopathy in a Mexican-American population: proyecto VER. Diabetes Care, 24 (7), 1204-9.
10. Harris, M.I., Klein, R., Cowie, C.C. et al. (1998) Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study. Diabetes Care, 21 (8), 1230-5.
11. Klein, R., Klein, B.E., Moss, S.E. and Linton, K.L. (1992) The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. Ophthalmology, 99 (1), 58-62.
12. Roy, M.S. (2000) Diabetic retinopathy in African Americans with type 1 diabetes: The New Jersey 725: I. Methodology, population, frequency of retinopathy, and visual impairment. Archives of Ophthalmology, 118 (1), 97-104.
13. Klein, R., Sharrett, A.R., Klein, B.E. et al. (2002) The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes: the atherosclerosis risk in communities study. Ophthalmology, 109 (7), 1225-34.
14. Klein, R., Marino, E.K., Kuller, L.H. et al. (2002) The relation of atherosclerotic cardiovascular disease to retinopathy in people with diabetes in the cardiovascular health study. The British Journal of Ophthalmology, 86 (1), 84-90.
15. Klein, R., Klein, B.E., Moss, S.E. et al. (1984) Prevalence of diabetes mellitus in southern Wisconsin. American Journal of Epidemiology, 119 (1), 54-61.
16. Klein, R., Klein, B.E., Moss, S.E. et al. (1984) The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Archives of Ophthalmology, 102 (4), 520-6.
17. Klein, R., Klein, B.E., Moss, S.E. et al. (1984) The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Archives of Ophthalmology, 102 (4), 527-32.
18. Klein, R., Klein, B.E., Moss, S.E. et al. (1984) The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IV. Diabetic macular edema. Ophthalmology, 91 (12), 1464-74.
19. Broadbent, D.M., Scott, J.A., Vora, J.P. and Harding, S.P. (1999) Prevalence of diabetic eye disease in an inner city population: the Liverpool Diabetic Eye Study. Eye, 13 (Pt 2), 160-5.
20. McKay, R., McCarty, C.A. and Taylor, H.R. (2000) Diabetic retinopathy in Victoria, Australia: the Visual Impairment Project. The British Journal of Ophthalmology, 84 (8), 865-70.
21. Leske, M.C., Wu, S.Y., Hyman, L. et al. (1999) Diabetic retinopathy in a black population: the Barbados Eye Study. Ophthalmology, 106 (10), 1893-99; [erratum: (2000) Ophthalmology, 107 (3), 412].
22. Mitchell, P., Smith, W., Wang, J.J. and Attebo, K. (1998) Prevalence of diabetic retinopathy in an older community. The Blue Mountains Eye Study. Ophthalmology, 105 (3), 406-11.
23. Stolk, R.P., Vingerling, J.R., de Jong, P.T. et al. (1995) Retinopathy, glucose, and insulin in an elderly population. The Rotterdam Study. Diabetes, 44 (1), 11-15.
24. Van Leiden, H.A., Dekker, J.M., Moll, A.C. et al. (2003) Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn Study. Archives of Ophthalmology, 121 (2), 245-51.
25. McLeod, B.K., Thompson, J.R. and Rosenthal, A.R. (1988) The prevalence of retinopathy in the insulin-requiring diabetic patients of an English country town. Eye, 2 (Pt 4), 424-30.
26. Sparrow, J.M., McLeod, B.K., Smith, T.D. et al. (1993) The prevalence of diabetic retinopathy and maculopathy and their risk factors in the non-insulin-treated diabetic patients of an English town. Eye, 7 (Pt 1), 158-63.
27. Foulds, W.S., McCuish, A., Barrie, T. et al. (1983) Diabetic retinopathy in the west of Scotland: its detection and prevalence, and the cost-effectiveness of a proposed screening programme. Health Bulletin, 41 (6), 318-26.
28. Sjolie, A.K. (1985) Ocular complications in insulin treated diabetes mellitus. An epidemiological study. Acta Ophthalmologica, Supplementum, 172, 1-77.
29. Tapp, R.J., Shaw, J.E., Harper, C.A. et al. (2003) The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care, 26 (6), 1731-7.
30. Zimmet, P., Alberti, K.G. and Shaw, J. (2001) Global and societal implications of the diabetes epidemic. Nature, 414 (6865), 782-7.
31. Pan, X.R., Yang, W.Y., Li, G.W. and Liu, J. (1997) Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care, 20 (11), 1664-9.
32. Ramachandran, A., Snehalatha, C., Latha, E. et al. (1997) Rising prevalence of NIDDM in an urban population in India. Diabetologia, 40 (2), 232-7.
33. Tan, C.E., Emmanuel, S.C., Tan, B.Y. and Jacob, E. (1999) Prevalence of diabetes and ethnic differences in cardiovascular risk factors. The 1992 Singapore National Health Survey. Diabetes Care, 22 (2), 241-7.
34. Cheah, J.S., Yeo, P.P., Thai, A.C. et al. (1985) Epidemiology of diabetes mellitus in Singapore: comparison with other ASEAN countries. Annals of the Academy of Medicine, Singapore, 14 (2), 232-9.
35. Narendran, V., John, R.K., Raghuram, A. et al. (2002) Diabetic retinopathy among self reported diabetics in southern India: a population based assessment. The British Journal of Ophthalmology, 86 (9), 1014-18.
36. Dandona, L., Dandona, R., Naduvilath, T.J. et al. (1999) Population based assessment of diabetic retinopathy in an urban population in southern India. The British Journal of Ophthalmology, 83 (8), 937-40.
37. Teuscher, A., Schnell, H. and Wilson, P.W. (1988) Incidence of diabetic retinopathy and relationship to baseline plasma glucose and blood pressure. Diabetes Care, 11 (3), 246-51.
38. Henricsson, M., Nystrom, L., Blohme, G. et al. (2003) The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care, 26 (2), 349-54.
39. Klein, R., Palta, M., Allen, C. et al. (1997) Incidence of retinopathy and associated risk factors from time of diagnosis of insulin-dependent diabetes. Archives of Ophthalmology, 115 (3), 351-56.
40. Tudor, S.M., Hamman, R.F., Baron, A. et al. (1998) Incidence and progression of diabetic retinopathy in Hispanics and non-Hispanic whites with type 2 diabetes. San Luis Valley Diabetes Study, Colorado. Diabetes Care, 21 (1), 53-61.
41. Porta, M., Sjoelie, A.K., Chaturvedi, N. et al. (2001) Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB prospective complications study. Diabetologia, 44 (12), 2203-9.
42. Nielsen, N.V. (1984) Diabetic retinopathy I. The course of retinopathy in insulin-treated diabetics. A one year epidemiological cohort study of diabetes mellitus. The Island of Falster, Denmark. Acta Ophthalmologica, 62 (2), 256-65.
43. Stratton, I.M., Kohner, E.M., Aldington, S.J. et al. (2001) UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia, 44 (2), 156-63.
44. Younis, N., Broadbent, D.M., Vora, J.P. et al. (2003) Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet, 361 (9353), 195-200.
45. Klein, R., Klein, B.E., Moss, S.E. et al. (1989) The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Archives of Ophthalmology, 107 (2), 237-43.
46. Klein, R., Klein, B.E., Moss, S.E. et al. (1989) The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Archives of Ophthalmology, 107 (2), 244-9.
47. Klein, R., Klein, B.E., Moss, S.E. and Cruickshanks, K.J. (1994) The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy [see comment]. Archives of Ophthalmology, 112 (9), 1217-28.
48. Klein, R., Moss, S.E., Klein, B.E. et al. (1989) The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XI. The incidence of macular edema. Ophthalmology, 96 (10), 1501-10.
49. Lloyd, C.E., Klein, R., Maser, R.E. et al. (1995) The progression of retinopathy over 2 years: the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study. Journal of Diabetes and its Complications, 9 (3), 140-8.
50. Mitchell, P. (1980) The prevalence of diabetic retinopathy: a study of 1300 diabetics from Newcastle and the Hunter Valley. Australian Journal of Ophthalmology, 8 (3), 241-6.
51. Holl, R.W., Lang, G.E., Grabert, M. et al. (1998) Diabetic retinopathy in pediatric patients with type-1 diabetes: effect of diabetes duration, prepubertal and pubertal onset of diabetes, and metabolic control. The Journal of Pediatrics, 132 (5), 790-4.
52. Fairchild, J.M., Hing, S.J., Donaghue, K.C. et al. (1994) Prevalence and risk factors for retinopathy in adolescents with type 1 diabetes. The Medical Journal of Australia, 160 (12), 757-62.
53. Zhang, L., Krzentowski, G., Albert, A. and Lefebvre, P.J. (2001) Risk of developing retinopathy in diabetes control and complications trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care, 24 (7), 1275-9.
54. Maguire, A., Chan, A., Cusumano, J. et al. (2005) The case for biennial retinopathy screening in children and adolescents. Diabetes Care, 28 (3), 509-13.
55. Dorf, A., Ballintine, E.J., Bennett, P.H. and Miller, M. (1976) Retinopathy in Pima Indians. Relationships to glucose level, duration of diabetes, age at diagnosis of diabetes, and age at examination in a population with a high prevalence of diabetes mellitus. Diabetes, 25 (7), 554-60.
56. Bennett, P.H., Rushforth, N.B., Miller, M. and LeCompte, P.M. (1976) Epidemiologic studies of diabetes in the Pima Indians. Recent Progress in Hormone Research, 32, 333-76.
57. Berinstein, D.M., Stahn, R.M., Welty, T.K. et al. (1997) The prevalence of diabetic retinopathy and associated risk factors among Sioux Indians. Diabetes Care, 20 (5), 757-9.
58. Lee, E.T., Lee, V.S., Lu, M. and Russell, D. (1992) Development of proliferative retinopathy in NIDDM. A follow-up study of American Indians in Oklahoma. Diabetes, 41 (3), 359-67.
59. Lee, E.T., Lee, V.S., Kingsley, R.M. et al. (1992) Diabetic retinopathy in Oklahoma Indians with NIDDM. Incidence and risk factors. Diabetes Care, 15 (11), 1620-7.
60. Varma, R., Torres, M., Pena, F. et al. (2004) Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino eye study. Ophthalmology, 111 (7), 1298-306.
61. Dowse, G.K., Humphrey, A.R., Collins, V.R. et al. (1998) Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. American Journal of Epidemiology, 147 (5), 448-57.
62. Collins, V.R., Dowse, G.K., Plehwe, W.E. et al. (1995) High prevalence of diabetic retinopathy and nephropathy in Polynesians of Western Samoa. Diabetes Care, 18 (8), 1140-9.
63. Fujimoto, W. and Fukuda, M. (1976) Natural history of diabetic retinopathy and its treatment in Japan, in Diabetes Mellitus in Asia (eds S. Baba, Y. Goto, I. Fukui), Excerpta Medica, Amsterdam, pp. 225-31.
64. Wong, T.Y., Klein, R., Islam, F.M. et al. (2006) Diabetic retinopathy in a multi-ethnic cohort in the United States. American Journal of Ophthalmology, 141 (3), 446-55.
65. Kernell, A., Dedorsson, I., Johansson, B. et al. (1997) Prevalence of diabetic retinopathy in children and adolescents with IDDM. A population-based multicentre study. Diabetologia, 40 (3), 307-10.
66. Harris, M.I., Klein, R., Welborn, T.A. and Knuiman, M.W. (1992) Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care, 15 (7), 815-19.
67. Klein, R., Klein, B.E., Moss, S.E. and Cruickshanks, K.J. (1998) The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology, 105 (10), 1801-15.
68. Krolewski, A.S., Warram, J.H., Rand, L.I. et al. (1986) Risk of proliferative diabetic retinopathy in juvenile-onset type I diabetes: a 40-yr follow-up study. Diabetes Care, 9 (5), 443-52.
69. Colwell, J.A. (1966) Effect of diabetic control on retinopathy. Diabetes, 15 (7), 497-9.
70. Miki, E., Fukuda, M., Kuzuya, T. et al. (1969) Relation of the course of retinopathy to control of diabetes, age, and therapeutic agents in diabetic Japanese patients. Diabetes, 18 (11), 773-80.
71. Doft, B.H., Kingsley, L.A., Orchard, T.J. et al. (1984) The association between long-term diabetic control and early retinopathy. Ophthalmology, 91 (7), 763-9.
72. Friberg, T.R., Rosenstock, J., Sanborn, G. et al. (1985) The effect of long-term near normal glycemic control on mild diabetic retinopathy. Ophthalmology, 92 (8), 1051-8.
73. The Kroc Collaborative Study Group (1984) Blood glucose control and the evolution of diabetic retinopathy and albuminuria. A preliminary multicenter trial. The Kroc Collaborative Study Group. The New England Journal of Medicine, 311 (6), 365-72.
74. Lauritzen, T., Frost-Larsen, K., Larsen, H.W. and Deckert, T. (1983) Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics. Lancet, 1 (8318), 200-4.
75. Klein, R. (1987) The epidemiology of diabetic retinopathy: findings from the Wisconsin Epidemiologic Study of Diabetic Retinopathy. International Ophthalmology Clinics, 27 (4), 230-8.
76. Klein, R., Klein, B.E., Moss, S.E. et al. (1988) Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. The Journal of the American Medical Association, 260 (19), 2864-71.
77. Klein, R., Klein, B.E., Moss, S.E. and Cruickshanks, K.J. (1994) Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Archives of Internal Medicine, 154 (19), 2169-78.
78. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The New England Journal of Medicine, 329 (14), 977-86.
79. The Diabetes Control and Complications Trial (1995) The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial. Archives of Ophthalmology, 113 (1), 36-51.
80. Diabetes Control and Complications Trial Research Group (1995) Progression of retinopathy with intensive versus conventional treatment in the diabetes control and complications trial. Diabetes Control and Complications Trial Research Group. Ophthalmology, 102 (4), 647-61.
81. Dahl-Jorgensen, K., Brinchmann-Hansen, O., Hanssen, K.F. et al. (1986) Effect of near normo-glycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study. British Medical Journal, 293 (6556), 1195-9.
82. The Diabetes Control and Complications Trial (1996) The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes, 45 (10), 1289-98.
83. Chaturvedi, N., Sjoelie, A.K., Porta, M. et al. (2001) Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes. Diabetes Care, 24 (2), 284-9.
84. The Diabetes Control and Complications Trial (2000) Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. The New England Journal of Medicine, 342 (6), 381-9; [erratum: (2000) The New England Journal of Medicine, 342 (18), 1376].
85. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 352 (9131), 837-53.
86. Klein, R., Klein, B.E., Moss, S.E. et al. (1989) Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? Archives of Internal Medicine, 149 (11), 2427-32.
87. Klein, B.E., Klein, R., Moss, S.E. and Palta, M. (1995) A cohort study of the relationship of diabetic retinopathy to blood pressure. Archives of Ophthalmology, 113 (5), 601-6 [erratum: (1996) Archives of Ophthalmology, 114 (1), 109].
88. Olsen, B.S., Sjolie, A., Hougaard, P. et al. (2000) A 6-year nationwide cohort study of glycaemic control in young people with type 1 diabetes. Risk markers for the development of retinopathy, nephropathy and neuropathy. Danish Study Group of Diabetes in Childhood. Journal of Diabetes and its Complications, 14 (6), 295-300.
89. UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. British Medical Journal, 317 (7160), 703-13.
90. Adler, A.I., Stratton, I.M., Neil, H.A. et al. (2000) Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. British Medical Journal, 321 (7258), 412-19.
91. Schrier, R.W., Estacio, R.O., Esler, A. and Mehler, P. (2002) Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney International, 61 (3), 1086-97.
92. Estacio, R.O., Jeffers, B.W., Gifford, N. and Schrier, R.W. (2000) Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care, 23 (Suppl 2), B54-64.
93. Fong, D.S., Aiello, L., Gardner, T.W. et al. (2003) Diabetic retinopathy. Diabetes Care, 26 (1), 226-29.
94. McCarty, C.A., McKay, R. and Keeffe, J.E. (2000) Management of diabetic retinopathy by Australian ophthalmologists. Working Group on evaluation of the NHMRC retinopathy guideline distribution. National Health and Medical Research Council. Clinical and Experimental Ophthalmology, 28 (2), 107-12.
95. Ferris, F.L. III, Chew, E.Y. and Hoogwerf, B.J. (1996) Serum lipids and diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Research Group. Diabetes Care, 19 (11), 1291-3.
96. Lyons, T.J., Jenkins, A.J., Zheng, D. et al. (2004) Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. Investigative Ophthalmology and Visual Science, 45 (3), 910-18.
97. Chew, E.Y. (1997) Diabetic retinopathy and lipid abnormalities. Current Opinion in Ophthalmology, 8 (3), 59-62.
98. Su, D.H. and Yeo, K.T. (2000) Diabetic retinopathy and serum lipids. Singapore Medical Journal, 41 (6), 295-7.
99. Cusick, M., Chew, E.Y., Chan, C.C. et al. (2003) Histopathology and regression of retinal hard exudates in diabetic retinopathy after reduction of elevated serum lipid levels. Ophthalmology, 110 (11), 2126-33.
100. Curtis, T.M. and Scholfield, C.N. (2004) The role of lipids and protein kinase Cs in the pathogenesis of diabetic retinopathy. Diabetes/Metabolism Research and Reviews, 20 (1), 28-43.
101. Cohen, R.A., Hennekens, C.H., Christen, W.G. et al. (1999) Determinants of retinopathy progression in type 1 diabetes mellitus. American Journal of Medicine, 107 (1), 45-51.
102. Nazimek-Siewniak, B., Moczulski, D. and Grzeszczak, W. (2002) Risk of macrovascular and microvascular complications in type 2 diabetes: results of longitudinal study design. The Journal of Diabetic Complications, 16 (4), 271-6.
103. Klein, B.E., Moss, S.E., Klein, R. and Surawicz, T.S. (1991) The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate. Ophthalmology, 98 (8), 1261-5.
104. Chew, E.Y., Klein, M.L., Ferris, F.L. III et al. (1996) Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) report 22. Archives of Ophthalmology, 114 (9), 1079-84.
105. Keech, A., Simes, R.J., Barter, P. et al. (2005) Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet, 366 (9500), 1849-61.
106. Gupta, A., Gupta, V., Thapar, S. and Bhansali, A. (2004) Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema. American Journal of Ophthalmology, 137 (4), 675-82.
107. Sen, K., Misra, A., Kumar, A. and Pandey, R.M. (2002) Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia. Diabetes Research and Clinical Practice, 56 (1), 1-11.
108. Gordon, B., Chang, S., Kavanagh, M. et al. (1991) The effects of lipid lowering on diabetic retinopathy. American Journal of Ophthalmology, 112 (4), 385-91.
109. Root, H., Pote, W.H. and Frehner, H. (1954) Triopathy of diabetes; sequence of neuropathy, retinopathy and nephropathy in one hundred fifty-five patients. Archives of Internal Medicine, 94 (6), 931-41.
110. Klein, R., Zinman, B., Gardiner, R. et al. (2005) The relationship of diabetic retinopathy to pre-clinical diabetic glomerulopathy lesions in type 1 diabetic patients: the rennin-angiotensin system study. Diabetes, 54 (2), 527-33.
111. Ballone, E., Colagrande, V., Di Nicola, M. et al. (2003) Probabilistic approach to developing nephropathy in diabetic patients with retinopathy. Statistics in Medicine, 22 (24), 3889-97.
112. Cruickshanks, K.J., Ritter, L.L., Klein, R. and Moss, S.E. (1993) The association of microalbuminuria with diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology, 100 (6), 862-7.
113. Klein, R., Moss, S.E. and Klein, B.E. (1993) Is gross proteinuria a risk factor for the incidence of proliferative diabetic retinopathy? Ophthalmology, 100 (8), 1140-6.
114. Bresnick, G.H. (1983) Diabetic maculopathy. A critical review highlighting diffuse macular edema. Ophthalmology, 90 (11), 1301-17.
115. Perkovich, B.T. and Meyers, S.M. (1988) Systemic factors affecting diabetic macular edema. American Journal of Ophthalmology, 105 (2), 211-12.
116. Uckaya, G., Ozata, M., Bayraktar, Z. et al. (2000) Is leptin associated with diabetic retinopathy? Diabetes Care, 23 (3), 371-6.
117. Van Leiden, H.A., Dekker, J.M., Moll, A.C. et al. (2002) Blood pressure, lipids, and obesity are associated with retinopathy: the Hoorn Study. Diabetes Care, 25 (8), 1320-5.
118. De Block, C.E., De Leeuw, I.H. and Van Gaal, L.F. (2005) Impact of overweight on chronic microvascular complications in type 1 diabetic patients. Diabetes Care, 28 (7), 1649-55.
119. Wong, T.Y., Duncan, B.B., Golden, S.H. et al. (2004) Associations between the metabolic syndrome and retinal microvascular signs: the atherosclerosis risk in communities study. Investigative Ophthalmology and Visual Science, 45 (9), 2949-54.
120. Klein, R., Klein, B.E. and Moss, S.E. (1997) Is obesity related to microvascular and macrovas-cular complications in diabetes? The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Archives of Internal Medicine, 157 (6), 650-6.
121. Chaturvedi, N. and Fuller, J.H. (1995) Mortality risk by body weight and weight change in people with NIDDM. The WHO multinational study of vascular disease in diabetes. Diabetes Care, 18 (6), 766-74.
122. Nelson, R.G., Wolfe, J.A., Horton, M.B. et al. (1989) Proliferative retinopathy in NIDDM. Incidence and risk factors in Pima Indians. Diabetes, 38 (4), 435-40.
123. Dorchy, H., Claes, C. and Verougstraete, C. (2002) Risk factors of developing proliferative retinopathy in type 1 diabetic patients: role of BMI. Diabetes Care, 25 (4), 798-9.
124. Aiello, L.P., Avery, R.L., Arrigg, P.G. et al. (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. New England Journal of Medicine, 331 (22), 1480-7.
125. Gariano, R.F., Nath, A.K., D'Amico, D.J. et al. (2000) Elevation of vitreous leptin in diabetic retinopathy and retinal detachment. Investigative Ophthalmology and Visual Science, 41 (11), 3576-81.
126. Sheard, N.F. (2003) Moderate changes in weight and physical activity can prevent or delay the development of type 2 diabetes mellitus in susceptible individuals. Nutrition Reviews, 61 (2), 76-9.
127. Tamburrino, M.B. and McGinnis, R.A. (2002) Anorexia nervosa. A review. Panminerva Medica, 44 (4), 301-11.
128. Chen, H.C., Newsom, R.S., Patel, V. et al. (1994) Retinal blood flow changes during pregnancy in women with diabetes. Investigative Ophthalmology and Visual Science, 35 (8), 3199-208.
129. Schocket, L.S., Grunwald, J.E., Tsang, A.F. and DuPont, J. (1999) The effect of pregnancy on retinal hemodynamics in diabetic versus nondiabetic mothers. American Journal of Ophthalmology, 128 (4), 477-84.
130. Sone, H., Okuda, Y., Kawakami, Y. et al. (1996) Progesterone induces vascular endothelial growth factor on retinal pigment epithelial cells in culture. Life Sciences, 59 (1), 21-5.
131. Moloney, J.B. and Drury, M.I. (1982) The effect of pregnancy on the natural course of diabetic retinopathy. American Journal of Ophthalmology, 93 (6), 745-56.
132. Klein, B.E., Moss, S.E. and Klein, R. (1990) Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care, 13 (1), 34-40.
133. Chew, E.Y., Mills, J.L., Metzger, B.E. et al. (1995) Metabolic control and progression of retinopathy. The diabetes in early pregnancy study. National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study. Diabetes Care, 18 (5), 631-7.
134. Hemachandra, A., Ellis, D., Lloyd, C.E. and Orchard, T.J. (1995) The influence of pregnancy on IDDM complications. Diabetes Care, 18 (7), 950-4.
135. Lovestam-Adrian, M., Agardh, C.D., Aberg, A. and Agardh, E. (1997) Pre-eclampsia is a potent risk factor for deterioration of retinopathy during pregnancy in type 1 diabetic patients. Diabetic Medicine, 14 (12), 1059-65.
136. Rosenn, B., Miodovnik, M., Kranias, G. et al. (1992) Progression of diabetic retinopathy in pregnancy: association with hypertension in pregnancy. American Journal of Obstetrics and Gynecology, 166 (4), 1214-18.
137. Klein, B.E., Moss, S.E. and Klein, R. (1990) Is menarche associated with diabetic retinopathy? Diabetes Care, 13 (10), 1034-8.
138. Klein, B.E., Moss, S.E. and Klein, R. (1990) Oral contraceptives in women with diabetes. Diabetes Care, 13 (8), 895-8.
139. Klein, B.E., Klein, R. and Moss, S.E. (1999) Exogenous estrogen exposures and changes in diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care, 22 (12), 1984-7.
140. Meigs, J.B., Hu, F.B., Rifai, N. and Manson, J.E. (2004) Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. The Journal of the American Medical Association, 291 (16), 1978-86.
141. Pradhan, A.D., Manson, J.E., Rifai, N. et al. (2001) C-reactive protein, interleukin6, and risk of developing type 2 diabetes mellitus. The Journal of the American Medical Association, 286 (3), 327-34.
142. Miyamoto, K., Khosrof, S., Bursell, S.E. et al. (1999) Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proceedings of the National Academy of Sciences of the United States of America, 96 (19), 10836-41.
143. Izuora, K.E., Chase, H.P., Jackson, W.E. et al. (2005) Inflammatory markers and diabetic retinopathy in type 1 diabetes. Diabetes Care, 28 (3), 714-15.
144. Joussen, A.M., Poulaki, V., Le, M.L. et al. (2004) A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB Journal, 18 (12), 1450-2.
145. Mitamura, Y., Takeuchi, S., Yamamoto, S. et al. (2002) Monocyte chemotactic protein-1 levels in the vitreous of patients with proliferative vitreo-retinopathy. Japanese Journal of Ophthalmology, 46 (2), 218-21.
146. Meleth, A.D., Agron, E., Chan, C.C. et al. (2005) Serum inflammatory markers in diabetic retinopathy. Investigative Ophthalmology and Visual Science, 46 (11), 4295-301.
147. Van Hecke, M.V., Dekker, J.M., Nijpels, G. et al. (2005) Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study. Diabetologia, 48 (7), 1300-6.
148. Schram, M.T., Chaturvedi, N., Schalkwijk, C.G. et al. (2005) Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes-the EURODIAB Prospective Complications Study. Diabetologia, 48 (2), 370-8.
149. Early Treatment Diabetic Retinopathy Study Research Group (1991) Effects of aspirin treatment on diabetic retinopathy. ETDRS report number 8. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology, 98 (Suppl 5), 757-65.
150. Moss, S.E., Klein, R. and Klein, B.E. (1991) Association of cigarette smoking with diabetic retinopathy. Diabetes Care, 14 (2), 119-26.
151. Moss, S.E., Klein, R. and Klein, B.E. (1996) Cigarette smoking and ten-year progression of diabetic retinopathy. Ophthalmology, 103 (9), 1438-42.
152. Moss, S.E., Klein, R. and Klein, B.E. (1992) Alcohol consumption and the prevalence of diabetic retinopathy. Ophthalmology, 99 (6), 926-32.
153. Moss, S.E., Klein, R. and Klein, B.E. (1994) The association of alcohol consumption with the incidence and progression of diabetic retinopathy. Ophthalmology, 101 (12), 1962-8.
154. Klein, R., Klein, B.E. and Moss, S.E. (1997) The relation of systemic hypertension to changes in the retinal vasculature: the Beaver Dam Eye Study. Transactions of the American Ophthalmological Society, 95, 329-48; discussion 348-50.
155. Kriska, A.M., LaPorte, R.E., Patrick, S.L. et al. (1991) The association of physical activity and diabetic complications in individuals with insulin-dependent diabetes mellitus: the Epidemiology of Diabetes Complications Study-VII. Journal of Clinical Epidemiology, 44 (11), 1207-14.
156. Cruickshanks, K.J., Moss, S.E., Klein, R. and Klein, B.E. (1992) Physical activity and proliferative retinopathy in people diagnosed with diabetes beforeage 30yr. Diabetes Care, 15 (10), 1267-72.
157. Wong, T.Y., Klein, R., Klein, B.E. et al. (2001) Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality. Survey of Ophthalmology, 46 (1), 59-80.
158. Wong, T.Y., Hubbard, L.D., Klein, R. et al. (2002) Retinal microvascular abnormalities and blood pressure in older people: the cardiovascular health study. The British Journal of Ophthalmology, 86 (9), 1007-13.
159. Wong, T.Y., Klein, R., Sharrett, A.R. et al. (2003) The prevalence and risk factors of retinal microvascular abnormalities in older persons: the cardiovascular health study. Ophthalmology, 110 (4), 658-66.
160. Yu, T., Mitchell, P., Berry, G. et al. (1998) Retinopathy in older persons without diabetes and its relationship to hypertension. Archives of Ophthalmology, 116 (1), 83-9.
161. Klein, R., Klein, B.E., Moss, S.E. and Wang, Q. (1994) Hypertension and retinopathy, arteriolar narrowing, and arteriovenous nicking in a population. Archives of Ophthalmology, 112 (1), 92-8.
162. Klein, R., Sharrett, A.R., Klein, B.E. et al. (2000) Are retinal arteriolar abnormalities related to atherosclerosis? The Atherosclerosis Risk in Communities Study. Arteriosclerosis, Thrombosis and Vascular Biology, 20 (6), 1644-50.
163. Cugati, S., Cikamatana, L., Wang, J.J. et al. (2005) Five-year incidence and progression of vascular retinopathy in persons without diabetes: the Blue Mountains Eye Study. Eye, 20 (11), 1239-45.
164. Wong, T.Y., Barr, E.L., Tapp, R.J. et al. (2005) Retinopathy in persons with impaired glucose metabolism: the Australian Diabetes Obesity and Lifestyle (AusDiab) Study. American Journal of Ophthalmology, 140 (6), 1157-9.
165. Rajala, U., Laakso, M., Qiao, Q. and Keinanen-Kiukaanniemi, S. (1998) Prevalence of retinopathy in people with diabetes, impaired glucose tolerance, and normal glucose tolerance. Diabetes Care, 21 (10), 1664-9.
166. Singleton, J.R., Smith, A.G., Russell, J.W. and Feldman, E.L. (2003) Microvascular complications of impaired glucose tolerance. Diabetes, 52 (12), 2867-73.
167. Wong, T.Y. and Mitchell, P. (2004) Hypertensive retinopathy. New England Journal of Medicine, 351 (22), 2310-17.
168. Wong, T.Y., Klein, R., Couper, D.J. et al. (2001) Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. Lancet, 358 (9288), 1134-40.
169. Wong, T.Y., Klein, R., Sharrett, A.R. et al. (2002) Cerebral white matter lesions, retinopathy, and incident clinical stroke. The Journal of the American Medical Association, 288 (1), 67-74.
170. Wong, T.Y., Mohamed, Q., Klein, R. and Couper, D.J. (2006) Do retinopathy signs in non-diabetic individuals predict the subsequent risk of diabetes? The British Journal of Ophthalmology, 90 (3), 301-3.
171. Klein, R., Klein, B.E. and Moss, S.E. (1992) Epidemiology of proliferative diabetic retinopathy. Diabetes Care, 15 (12), 1875-91.
172. Wong, T.Y., Rosamond, W., Chang, P.P. et al. (2005) Retinopathy and risk of congestive heart failure. The Journal of the American Medical Association, 293 (1), 63-9.
173. Van Hecke, M.V., Dekker, J.M., Nijpels, G. et al. (2003) Retinopathy is associated with cardiovascular and all-cause mortality in both diabetic and nondiabetic subjects: the Hoorn Study. Diabetes Care, 26 (10), 2958.
174. Van Hecke, M.V., Dekker, J.M., Stehouwer, C.D. et al. (2005) Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB Prospective Complications Study. Diabetes Care, 28 (6), 1383-9.
175. Cusick, M., Meleth, A.D., Agron, E. et al. (2005) Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes: Early Treatment Diabetic Retinopathy Study report no. 27. Diabetes Care, 28 (3), 617-25.
176. Miettinen, H., Haffner, S.M., Lehto, S. et al. (1996) Retinopathy predicts coronary heart disease events in NIDDM patients. Diabetes Care, 19 (12), 1445-8.
177. Mitchell, P., Wang, J.J., Wong, T.Y. et al. (2005) Retinal microvascular signs and risk of stroke and stroke mortality. Neurology, 65 (7), 1005-9.
178. Cooper, L.S., Wong, T.Y., Klein, R. et al. (2006) Retinal microvascular abnormalities and MRI-defined subclinical cerebral infarction: the Atherosclerosis Risk in Communities Study. Stroke, 37 (1), 82-6.
179. Klein, R., Klein, B.E., Moss, S.E. and Meuer, S.M. (2000) The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Transactions of the American Ophthalmological Society, 98, 133-41; discussion 141-43.
180. Mitchell, P., Smith, W. and Chang, A. (1996) Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Archives of Ophthalmology, 114 (10), 1243-7.
181. Shahsuvaryan, M.L. and Melkonyan, A.K. (2003) Central retinal vein occlusion risk profile: a case-control study. European Journal of Ophthalmology, 13 (5), 445-52.
182. Sperduto, R.D., Hiller, R., Chew, E. et al. (1998) Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease case-control study [see comment]. Ophthalmology, 105 (5), 765-71.
183. Rath, E.Z., Frank, R.N., Shin, D.H. and Kim, C. (1992) Risk factors for retinal vein occlusions. A case-control study. Ophthalmology, 99 (4), 509-14.
184. Hayreh, S.S., Zimmerman, B., McCarthy, M.J. and Podhajsky, P. (2001) Systemic diseases associated with various types of retinal vein occlusion. American Journal of Ophthalmology, 131 (1), 61-77.
185. The Eye Disease Case-Control Study Group (1996) Risk factors for central retinal vein occlusion. Archives of Ophthalmology, 114 (5), 545-54.
186. Wong, T.Y., Larsen, E.K., Klein, R. et al. (2005) Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the Atherosclerosis Risk in Communities & Cardiovascular Health Studies. Ophthalmology, 112 (4), 540-7.
187. Funderburk, R.L. and Feinberg, E.B. (1989) Diabetes as a risk factor for retinal neovascularization in retinal vein occlusion. Annals of Ophthalmology, 21 (2), 65-6.
188. Mitchell, P., Wang, J.J., Li, W. et al. (1997) Prevalence of asymptomatic retinal emboli in an Australian urban community. Stroke, 28 (1), 63-6.
189. Klein, R., Klein, B.E., Jensen, S.C. et al. (1999) Retinal emboli and stroke: the Beaver Dam Eye Study. Archives of Ophthalmology, 117 (8), 1063-8.
190. Klein, R., Klein, B.E., Moss, S.E. and Meuer, S.M. (2003) Retinal emboli and cardiovascular disease: the Beaver Dam Eye Study. Archives of Ophthalmology, 121 (10), 1446-51.
191. Wong, T.Y. and Klein, R. (2002) Retinal arteriolar emboli: epidemiology and risk of stroke. Current Opinion in Ophthalmology, 13 (3), 142-6.
192. Cugati, S., Wang, J.J., Rochtchina, E. and Mitchell, P. (2006) Ten-year incidence of retinal emboli in an older population. Stroke, 37 (3), 908-10.
193. Recchia, F.M. and Brown, G.C. (2000) Systemic disorders associated with retinal vascular occlusion. Current Opinion in Ophthalmology, 11 (6), 462-7.
194. Wilson, L.A., Warlow, C.P. and Russell, R.W. (1979) Cardiovascular disease in patients with retinal arterial occlusion. Lancet, 1 (8111), 292-4.
195. Mizener, J.B., Podhajsky, P. and Hayreh, S.S. (1997) Ocular ischemic syndrome. Ophthalmology, 104 (5), 859-64.
196. Dogru, M., Inoue, M., Nakamura, M. and Yamamoto, M. (1998) Modifying factors related to asymmetric diabetic retinopathy. Eye, 12 (Pt 6), 929-33.
197. Duker, J.S., Brown, G.C., Bosley, T.M. et al. (1990) Asymmetric proliferative diabetic retinopathy and carotid artery disease. Ophthalmology, 97 (7), 869-74.
198. Moss, S.E., Klein, R. and Klein, B.E. (1994) Ocular factors in the incidence and progression of diabetic retinopathy. Ophthalmology, 101 (1), 77-83.
199. Hayreh, S.S., Joos, K.M., Podhajsky, P.A. and Long, C.R. (1994) Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. American Journal of Ophthalmology, 118 (6), 766-80.
200. Jacobson, D.M., Vierkant, R.A. and Belongia, E.A. (1997) Nonarteritic anterior ischemic optic neuropathy. A case-control study of potential risk factors. Archives of Ophthalmology, 115 (11), 1403-7.
201. The Ischemic Optic Neuropathy Decompression Trial Research Group (1996) Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Archives of Ophthalmology, 114 (11), 1366-74.
202. Patel, S.V., Holmes, J.M., Hodge, D.O. and Burke, J.P. (2005) Diabetes and hypertension in isolated sixth nerve palsy: a population-based study. Ophthalmology, 112 (5), 760-3.
203. Hiller, R., Sperduto, R.D. and Ederer, F. (1986) Epidemiologic associations with nuclear, cortical, and posterior subcapsular cataracts. American Journal of Epidemiology, 124 (6), 916-25.
204. Miglior, S., Marighi, P.E., Musicco, M. et al. (1994) Risk factors for cortical, nuclear, posterior subcapsular and mixed cataract: a case-control study. Ophthalmic Epidemiology, 1 (2), 93-105.
205. Delcourt, C., Cristol, J.P., Tessier, F. et al. (2000) Risk factors for cortical, nuclear, and posterior subcapsular cataracts: the POLA study. Pathologies Oculaires Liees a l'Age. American Journal of Epidemiology, 151 (5), 497-504.
206. Klein, B.E., Klein, R., Wang, Q. and Moss, S.E. (1995) Older-onset diabetes and lens opacities. The Beaver Dam Eye Study. Ophthalmic Epidemiology, 2 (1), 49-55.
207. Klein, B.E., Klein, R. and Lee, K.E. (1998) Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: the Beaver Dam Eye Study. American Journal of Ophthalmology, 126 (6), 782-90.
208. Rowe, N.G., Mitchell, P.G., Cumming, R.G. and Wans, J.J. (2000) Diabetes, fasting blood glucose and age-related cataract: the Blue Mountains Eye Study. Ophthalmic Epidemiology, 7 (2), 103-14.
209. Saxena, S., Mitchell, P. and Rochtchina, E. (2004) Five-year incidence of cataract in older persons with diabetes and pre-diabetes. Ophthalmic Epidemiology, 11 (4), 271-7.
210. McCarty, C.A., Mukesh, B.N., Fu, C.L. and Taylor, H.R. (1999) The epidemiology of cataract in Australia. American Journal of Ophthalmology, 128 (4), 446-65.
211. Mukesh, B.N., Le, A., Dimitrov, P.N. et al. (2006) Development of cataract and associated risk factors: the visual impairment project. Archives of Ophthalmology, 124 (1), 79-85.
212. Leske, M.C., Chylack, L.T. Jrand Wu, S.Y. (1991) The lens opacities case-control study. Risk factors for cataract. Archives of Ophthalmology, 109 (2), 244-51.
213. Hennis, A., Wu, S.Y., Nemesure, B. et al. (2004) Risk factors for incident cortical and posterior subcapsular lens opacities in the Barbados Eye Studies. Archives of Ophthalmology, 122 (4), 525-30.
214. Foster, P.J., Wong, T.Y., Machin, D. et al. (2003) Risk factors for nuclear, cortical and posterior subcapsular cataracts in the Chinese population of Singapore: the Tanjong Pagar survey. British Journal of Ophthalmology, 87 (9), 1112-20.
215. Tsai, S.Y., Hsu, W.M., Cheng, C.Y. et al. (2003) Epidemiologic study of age-related cataracts among an elderly Chinese population in Shih-Pai, Taiwan. Ophthalmology, 110 (6), 1089-95.
216. Nirmalan, P.K., Robin, A.L., Katz, J. et al. (2004) Risk factors for age related cataract in a rural population of southern India: the Aravind Comprehensive Eye Study. The British Journal of Ophthalmology, 88 (8), 989-94.
217. Leske, M.C., Wu, S.Y., Hennis, A. et al. (1999) Diabetes, hypertension, and central obesity as cataract risk factors in a black population. The Barbados Eye Study. Ophthalmology, 106 (1), 35-41.
218. Harding, J.J., Harding, R.S. and Egerton, M. (1989) Risk factors for cataract in Oxfordshire: diabetes, peripheral neuropathy, myopia, glaucoma and diarrhoea. Acta Ophthalmologica, 67 (5), 510-17.
219. Harding, J.J., Egerton, M., van Heyningen, R. and Harding, R.S. (1993) Diabetes, glaucoma, sex, and cataract: analysis of combined data from two case control studies. The British Journal of Ophthalmology, 77 (1), 2-6.
220. Bron, A.J., Sparrow, J., Brown, N.A. et al. (1993) The lens in diabetes. Eye, 7 (Pt 2), 260-75.
221. Kato, S., Shiokawa, A., Fukushima, H. et al. (2001) Glycemic control and lens transparency in patients with type 1 diabetes mellitus. American Journal of Ophthalmology, 131 (3), 301-4.
222. Klein, B.E., Klein, R. and Moss, S.E. (1995) Incidence of cataract surgery in the Wisconsin Epidemiologic Study of Diabetic Retinopathy. American Journal of Ophthalmology, 119 (3), 295-300.
223. Lee, A.Y. and Chung, S.S. (1999) Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB Journal, 13 (1), 23-30.
224. Kinoshita, J.H., Merola, L.O., Satoh, K. and Dimak, E. (1962) Osmotic changes caused by the accumulation of dulcitol in the lenses of rats fed with galactose. Nature, 194, 1085-7.
225. Van Heyningen, R. (1959) Formations of polyols by the lens of the rat with sugar cataract. Nature, 184, 194-5.
226. Dvornik, E., Simard-Duquesne, N., Krami, M. et al. (1973) Polyol accumulation in galactosemic and diabetic rats: control by an aldose reductase inhibitor. Science, 182 (117), 1146-8.
227. Agardh, E., Hultberg, B. and Agardh, C. (2000) Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats. Current Eye Research, 21 (1), 543-9.
228. Lee, S.C., Wang, Y., Ko, G.T. et al. (2001) Risk factors for cataract in Chinese patients with type 2 diabetes: evidence for the influence of the aldose reductase gene. Clinical Genetics, 59 (5), 356-9.
229. Becker, B. (1971) Diabetes mellitus and primary open-angle glaucoma. The XXVII Edward Jackson Memorial Lecture. American Journal of Ophthalmology, 1 (1 Pt 1), 1-16.
230. Kahn, H.A. and Milton, R.C. (1980) Revised Framingham Eye Study prevalence of glaucoma and diabetic retinopathy. American Journal of Epidemiology, 111 (6), 769-76.
231. Klein, B.E., Klein, R. and Moss, S.E. (1984) Intraocular pressure in diabetic persons. Ophthalmology, 91 (11), 1356-60.
232. Mapstone, R. and Clark, C.V. (1985) Prevalence of diabetes in glaucoma. British Medical Journal (Clinical Research Education), 291 (6488), 93-5.
233. Nakamura, M., Kanamori, A. and Negi, A. (2005) Diabetes mellitus as a risk factor for glaucomatous optic neuropathy. Ophthalmologica, 219 (1), 1-10.
234. Mitchell, P., Smith, W., Chey, T. and Healey, P.R. (1997) Open-angle glaucoma and diabetes: the Blue Mountains Eye Study, Australia. Ophthalmology, 104 (4), 712-18.
235. Dielemans, I., de Jong, P.T., Stolk, R. et al. (1996) Primary open-angle glaucoma, intraocular pressure, and diabetes mellitus in the general elderly population. The Rotterdam Study. Ophthalmology, 103 (8), 1271-5.
236. Hennis, A., Wu, S.Y., Nemesure, B. et al. (2003) Hypertension, diabetes, and longitudinal changes in intraocular pressure. Ophthalmology, 110 (5), 908-14.
237. Lin, H.Y., Hsu, W.M., Chou, P. et al. (2005) Intraocular pressure measured with a noncontact tonometer in an elderly Chinese population: the Shihpai Eye Study. Archives of Ophthalmology, 123 (3), 381-6.
238. Tielsch, J.M., Katz, J., Quigley, H.A. et al. (1995) Diabetes, intraocular pressure, and primary open-angle glaucoma in the Baltimore Eye Survey. Ophthalmology, 102 (1), 48-53.
239. Vijaya, L., George, R., Paul, P.G. et al. (2005) Prevalence of open-angle glaucoma in a rural south Indian population. Investigative Ophthalmology and Visual Science, 46 (12), 4461-7.
240. Flammer, J., Orgul, S., Costa, V.P. et al. (2002) The impact of ocular blood flow in glaucoma. Progress in Retinal and Eye Research, 21 (4), 359-93.
241. Piltzseymour, J.R., Grunwald, J.E., Hariprasad, S.M. and Dupont, J. (2001) Optic nerve blood flow is diminished in eyes of primary open-angle glaucoma suspects. American Journal of Ophthalmology, 132 (1), 63-9.
242. Logan, J.F., Rankin, S.J. and Jackson, A.J. (2004) Retinal blood flow measurements and neuroretinal rim damage in glaucoma. British Journal of Ophthalmology, 88 (8), 1049-54.
243. Grunwald, J.E., Riva, C.E., Stone, R.A. et al. (1984) Retinal autoregulation in open-angle glaucoma. Ophthalmology, 91 (12), 1690-4.
244. Hayreh, S.S. (1999) The role of age and cardiovascular disease in glaucomatous optic neuropathy. Survey of Ophthalmology, 43 (Suppl 1), S27-42.